Semaphorin 7a + Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis

Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation. To define the relationship between Sema 7a and lymphocytes in IPF. We characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mo...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 187; no. 2; pp. 180 - 188
Main Authors Reilkoff, Ronald A., Peng, Hong, Murray, Lynne A., Peng, Xueyan, Russell, Thomas, Montgomery, Ruth, Feghali-Bostwick, Carol, Shaw, Albert, Homer, Robert J., Gulati, Mridu, Mathur, Aditi, Elias, Jack A., Herzog, Erica L.
Format Journal Article
LanguageEnglish
Published New York, NY American Thoracic Society 15.01.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation. To define the relationship between Sema 7a and lymphocytes in IPF. We characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4+CD25+FoxP3+ in TGF-β1-induced murine lung fibrosis. Subjects with IPF show expression of Sema 7a on lung CD4+ cells and circulating CD4+ or CD19+ cells. Sema 7a expression is increased on CD4+ cells and CD4+CD25+FoxP3+ regulatory T cells, but not CD19+ cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1-transgenic mice. Sema 7a expressing bone marrow-derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4+CD25+FoxP3+ cells, Sema7a+CD4+CD25+FoxP3+ cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1-exposed murine lung. Sema 7a+CD4+CD25+FoxP3+ regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1-exposed murine lung.
AbstractList Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation. To define the relationship between Sema 7a and lymphocytes in IPF. We characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4+CD25+FoxP3+ in TGF-β1-induced murine lung fibrosis. Subjects with IPF show expression of Sema 7a on lung CD4+ cells and circulating CD4+ or CD19+ cells. Sema 7a expression is increased on CD4+ cells and CD4+CD25+FoxP3+ regulatory T cells, but not CD19+ cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1-transgenic mice. Sema 7a expressing bone marrow-derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4+CD25+FoxP3+ cells, Sema7a+CD4+CD25+FoxP3+ cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1-exposed murine lung. Sema 7a+CD4+CD25+FoxP3+ regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1-exposed murine lung.
Rationale : Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation. Objectives : To define the relationship between Sema 7a and lymphocytes in IPF. Methods : We characterized the significance of Sema 7a + lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4 + CD25 + FoxP3 + in TGF-β1–induced murine lung fibrosis. Measurements and Main Results : Subjects with IPF show expression of Sema 7a on lung CD4 + cells and circulating CD4 + or CD19 + cells. Sema 7a expression is increased on CD4 + cells and CD4 + CD25 + FoxP3 + regulatory T cells, but not CD19 + cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1–transgenic mice. Sema 7a expressing bone marrow–derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4 + CD25 + FoxP3 + cells, Sema7a + CD4 + CD25 + FoxP3 + cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1–exposed murine lung. Conclusions : Sema 7a + CD4 + CD25 + FoxP3 + regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1–exposed murine lung.
Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation.RATIONALELymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation.To define the relationship between Sema 7a and lymphocytes in IPF.OBJECTIVESTo define the relationship between Sema 7a and lymphocytes in IPF.We characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4+CD25+FoxP3+ in TGF-β1-induced murine lung fibrosis.METHODSWe characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4+CD25+FoxP3+ in TGF-β1-induced murine lung fibrosis.Subjects with IPF show expression of Sema 7a on lung CD4+ cells and circulating CD4+ or CD19+ cells. Sema 7a expression is increased on CD4+ cells and CD4+CD25+FoxP3+ regulatory T cells, but not CD19+ cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1-transgenic mice. Sema 7a expressing bone marrow-derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4+CD25+FoxP3+ cells, Sema7a+CD4+CD25+FoxP3+ cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1-exposed murine lung.MEASUREMENTS AND MAIN RESULTSSubjects with IPF show expression of Sema 7a on lung CD4+ cells and circulating CD4+ or CD19+ cells. Sema 7a expression is increased on CD4+ cells and CD4+CD25+FoxP3+ regulatory T cells, but not CD19+ cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1-transgenic mice. Sema 7a expressing bone marrow-derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4+CD25+FoxP3+ cells, Sema7a+CD4+CD25+FoxP3+ cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1-exposed murine lung.Sema 7a+CD4+CD25+FoxP3+ regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1-exposed murine lung.CONCLUSIONSSema 7a+CD4+CD25+FoxP3+ regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1-exposed murine lung.
Author Shaw, Albert
Reilkoff, Ronald A.
Feghali-Bostwick, Carol
Mathur, Aditi
Herzog, Erica L.
Peng, Hong
Homer, Robert J.
Elias, Jack A.
Montgomery, Ruth
Russell, Thomas
Peng, Xueyan
Gulati, Mridu
Murray, Lynne A.
Author_xml – sequence: 1
  givenname: Ronald A.
  surname: Reilkoff
  fullname: Reilkoff, Ronald A.
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
– sequence: 2
  givenname: Hong
  surname: Peng
  fullname: Peng, Hong
  organization: Department of Respiratory Medicine, Second Xiangyia Hospital of Central-South University, Changsha, Hunan, PR China
– sequence: 3
  givenname: Lynne A.
  surname: Murray
  fullname: Murray, Lynne A.
  organization: MedImmune Ltd, Granta Park, Cambridgeshire, United Kingdom
– sequence: 4
  givenname: Xueyan
  surname: Peng
  fullname: Peng, Xueyan
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
– sequence: 5
  givenname: Thomas
  surname: Russell
  fullname: Russell, Thomas
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
– sequence: 6
  givenname: Ruth
  surname: Montgomery
  fullname: Montgomery, Ruth
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
– sequence: 7
  givenname: Carol
  surname: Feghali-Bostwick
  fullname: Feghali-Bostwick, Carol
  organization: Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania; and
– sequence: 8
  givenname: Albert
  surname: Shaw
  fullname: Shaw, Albert
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
– sequence: 9
  givenname: Robert J.
  surname: Homer
  fullname: Homer, Robert J.
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, Department of Pathology, West Haven Veterans Affairs Medical Center, West Haven, Connecticut
– sequence: 10
  givenname: Mridu
  surname: Gulati
  fullname: Gulati, Mridu
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
– sequence: 11
  givenname: Aditi
  surname: Mathur
  fullname: Mathur, Aditi
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
– sequence: 12
  givenname: Jack A.
  surname: Elias
  fullname: Elias, Jack A.
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
– sequence: 13
  givenname: Erica L.
  surname: Herzog
  fullname: Herzog, Erica L.
  organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, Department of Pathology, West Haven Veterans Affairs Medical Center, West Haven, Connecticut
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26898096$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23220917$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAUhSNURH_gBVggb5CQqhT_JHGyQRqNmDJSpVYwC3bWzY0zY5TYwU5aseMd-iZ9EB6CJ8HTGcqfxMqW_J1z7OtznBxYZ3WSPGf0jLEie-0R-zNOGadFyhitLuePkiOWizzNKkkP4p5KkWZZ9fEwOQ7hE41oyeiT5JALzmnF5FFy90H3MGycN5ZIIKfkvV5PHYzOfyErMtddF8jMazILwaGBUTfkxowbcuXd2usQzLUmy8a4AcaNQXI1db2zEMULU3sXTCBgm3uHZT90Bu8dYtbKgw2t872xa3Lu3U30XADG3PTbHfv-9dbYZsLI_uv4NHncQhf0s_16kqwWb1fzd-nF5flyPrtIUWQS0zJrUZdcV1CCyBBBY8MKKCQ0dc0ow7zlwOqGF1ICLWkDZY2iroq6haqS4iR5s7MdprrXDWo7eujU4E0fb6McGPXniTUbtXbXSuSSFrmIBq_2Bt59nnQYVW8CxomC1W4KinEp8jKiRURf_J71EPLznyLwcg9AQOjaOD004RdXlFVJq60R33EYRxW8bh8QRtW2NGpbGrUrjdqVJorKv0RoRhiN277LdP-T_gB0rs7B
CitedBy_id crossref_primary_10_1186_s13075_020_2112_7
crossref_primary_10_1155_2019_1907807
crossref_primary_10_3390_ijms25136847
crossref_primary_10_3390_jcm10071427
crossref_primary_10_1038_s41388_020_1192_9
crossref_primary_10_1371_journal_pone_0275987
crossref_primary_10_1007_s12026_013_8460_5
crossref_primary_10_1165_rcmb_2017_0171TR
crossref_primary_10_1177_1753425919861774
crossref_primary_10_1164_rccm_202306_0979OC
crossref_primary_10_1152_ajplung_00014_2014
crossref_primary_10_1371_journal_pone_0170207
crossref_primary_10_3389_fimmu_2016_00516
crossref_primary_10_1016_j_rmed_2018_12_015
crossref_primary_10_1016_j_redox_2015_09_009
crossref_primary_10_1016_j_matbio_2018_01_023
crossref_primary_10_1038_icb_2017_22
crossref_primary_10_4081_dr_2024_10106
crossref_primary_10_18093_0869_0189_2017_27_1_56_64
crossref_primary_10_1016_j_cellsig_2020_109647
crossref_primary_10_1016_j_matbio_2023_06_006
crossref_primary_10_1172_JCI125014
crossref_primary_10_1126_scitranslmed_aar8356
crossref_primary_10_1172_JCI136542
crossref_primary_10_1016_j_ajpath_2016_03_020
crossref_primary_10_1016_j_yjmcc_2017_11_001
crossref_primary_10_1371_journal_pone_0159878
crossref_primary_10_1007_s12035_016_0154_2
crossref_primary_10_1016_S2213_2600_18_30508_3
crossref_primary_10_2147_IJGM_S474827
crossref_primary_10_3389_fmed_2014_00056
crossref_primary_10_1007_s40139_013_0017_8
crossref_primary_10_1155_2019_9019648
crossref_primary_10_1096_fj_201600373R
crossref_primary_10_3389_fimmu_2024_1436491
crossref_primary_10_1016_j_yrmex_2019_100002
crossref_primary_10_1016_j_jbior_2023_100975
crossref_primary_10_1016_j_semarthrit_2020_01_006
crossref_primary_10_3389_fimmu_2021_690375
crossref_primary_10_1007_s40259_020_00437_8
crossref_primary_10_1080_17476348_2019_1553620
crossref_primary_10_1097_MCP_0000000000000187
crossref_primary_10_1186_1755_1536_6_20
crossref_primary_10_1007_s10157_018_1542_x
crossref_primary_10_1126_scitranslmed_3007096
crossref_primary_10_1016_S2213_2600_17_30349_1
crossref_primary_10_3389_fimmu_2021_663203
crossref_primary_10_3389_fphar_2022_918771
crossref_primary_10_1016_j_prp_2023_154901
crossref_primary_10_3389_fgene_2025_1544007
crossref_primary_10_1111_crj_12281
crossref_primary_10_1002_jcp_30340
crossref_primary_10_1038_pr_2013_222
crossref_primary_10_1183_16000617_0117_2017
crossref_primary_10_1111_apm_13445
crossref_primary_10_1155_2023_4835710
crossref_primary_10_1172_jci_insight_92192
crossref_primary_10_1136_bmjresp_2023_001763
crossref_primary_10_70322_fibrosis_2025_10004
crossref_primary_10_1016_j_clim_2013_11_009
crossref_primary_10_1111_jcmm_14186
crossref_primary_10_3389_fphar_2014_00080
crossref_primary_10_1186_s12931_017_0653_3
crossref_primary_10_1615_CritRevImmunol_2023047301
crossref_primary_10_3390_cimb46090609
crossref_primary_10_1183_13993003_01826_2015
crossref_primary_10_12688_f1000research_8209_1
crossref_primary_10_1016_j_pharmthera_2019_05_014
crossref_primary_10_1016_j_intimp_2020_106443
crossref_primary_10_1016_j_ajpath_2016_06_002
crossref_primary_10_1111_resp_12144
crossref_primary_10_1164_rccm_201405_0856UP
crossref_primary_10_1164_rccm_201902_0318ED
crossref_primary_10_1016_j_ebiom_2023_104766
crossref_primary_10_3389_fmed_2018_00043
crossref_primary_10_1007_s10238_022_00945_7
crossref_primary_10_1186_s12967_016_1008_4
crossref_primary_10_1186_s12916_015_0403_7
crossref_primary_10_1007_s00408_017_9993_5
crossref_primary_10_1146_annurev_physiol_021113_170411
crossref_primary_10_1016_j_chest_2024_10_042
crossref_primary_10_3389_fmed_2022_955125
crossref_primary_10_1016_j_crimmu_2023_100060
crossref_primary_10_1002_advs_202415007
crossref_primary_10_1097_MCP_0b013e328363f4b7
crossref_primary_10_1002_ctd2_70003
crossref_primary_10_1111_imr_12801
crossref_primary_10_4049_jimmunol_2100767
crossref_primary_10_1586_17476348_2015_1062367
crossref_primary_10_1164_rccm_202003_0669OC
crossref_primary_10_1002_path_5838
crossref_primary_10_1158_0008_5472_CAN_18_1642
crossref_primary_10_1038_s41420_023_01344_x
crossref_primary_10_3389_fimmu_2022_865593
crossref_primary_10_1152_ajplung_00100_2013
crossref_primary_10_3389_fmicb_2022_943791
crossref_primary_10_1080_14728222_2022_2114897
crossref_primary_10_3389_fimmu_2024_1450688
crossref_primary_10_4049_jimmunol_1600610
Cites_doi 10.4049/jimmunol.1102084
10.1152/ajplung.00439.2007
10.1016/j.immuni.2008.02.012
10.1084/jem.20092121
10.1164/rccm.200703-463PP
10.1084/jem.20040104
10.1038/nature01790
10.5858/2010-0296-RA.1
10.1186/1755-1536-3-18
10.1038/labinvest.2010.73
10.1038/nature05652
10.1002/jlb.65.2.187
10.1002/art.30386
10.1371/journal.pone.0009683
10.1016/j.ajpath.2012.01.010
10.1164/rccm.2009-040GL
10.1164/rccm.201103-0516OC
10.1016/j.immuni.2006.03.013
10.1002/dneu.20592
10.4049/jimmunol.1201140
10.2353/ajpath.2008.071049
10.1371/journal.pone.0015404
10.1371/journal.pone.0005981
10.1189/jlb.0707504
10.1038/nprot.2007.258
10.1016/j.biocel.2010.10.013
10.1164/ajrccm.165.2.ats01
10.1164/rccm.200812-1936OC
10.1371/journal.pone.0008959
10.1172/JCI36498
10.3748/wjg.v17.i3.343
ContentType Journal Article
Copyright 2014 INIST-CNRS
Copyright © 2013 by the American Thoracic Society 2013
Copyright_xml – notice: 2014 INIST-CNRS
– notice: Copyright © 2013 by the American Thoracic Society 2013
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1164/rccm.201206-1109OC
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1535-4970
EndPage 188
ExternalDocumentID PMC3570653
23220917
26898096
10_1164_rccm_201206_1109OC
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: K24 AG042489
– fundername: NHLBI NIH HHS
  grantid: U01 HL112702-01
– fundername: NIAID NIH HHS
  grantid: HHSN272201100019C
– fundername: NHLBI NIH HHS
  grantid: R01 HL109033
– fundername: NHLBI NIH HHS
  grantid: R01 HL109233
– fundername: NHLBI NIH HHS
  grantid: U01 HL112702
– fundername: NIAID NIH HHS
  grantid: HHSN272201100019I
GroupedDBID ---
-~X
.55
0R~
23M
2WC
34G
39C
53G
5GY
5RE
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8FW
8R4
8R5
AAWTL
AAYXX
ABJNI
ABOCM
ABPMR
ABUWG
ACGFO
ACGFS
ADBBV
AENEX
AFCHL
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AN0
BAWUL
BENPR
BKEYQ
BNQBC
BPHCQ
BVXVI
C45
CCPQU
CITATION
CS3
DIK
E3Z
EBS
EJD
EMOBN
EX3
F5P
FRP
FYUFA
GX1
H13
HMCUK
HZ~
IH2
J5H
KQ8
L7B
M1P
M5~
NAPCQ
O9-
OBH
OFXIZ
OGEVE
OK1
OVD
OVIDX
P2P
PCD
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
RWL
SJN
TAE
TEORI
THO
TR2
UKHRP
W8F
WH7
WOQ
WOW
X7M
ZXP
~02
.GJ
1CY
1KJ
3O-
AAEJM
AAQQT
ACBNA
AFFNX
AFUWQ
AI.
AJJEV
IQODW
N4W
OHT
PJZUB
PPXIY
VH1
YJK
ZE2
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c347c-84fce82e9a8a34ccaecd16a67adbb101c5f2a1bd2677a080da8bc3b96bfa9973
ISSN 1073-449X
1535-4970
IngestDate Thu Aug 21 18:28:17 EDT 2025
Tue Aug 05 11:24:15 EDT 2025
Mon Jul 21 05:56:37 EDT 2025
Mon Jul 21 09:13:59 EDT 2025
Tue Jul 01 00:53:41 EDT 2025
Thu Apr 24 23:06:06 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Lung disease
Intensive care
Respiratory disease
Idiopathic
lung
regulatory T cells
Pulmonary fibrosis
T-Lymphocyte
TGF-β1
fibrosis
Transforming growth factor β1
Resuscitation
Semaphorin
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c347c-84fce82e9a8a34ccaecd16a67adbb101c5f2a1bd2677a080da8bc3b96bfa9973
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/3570653
PMID 23220917
PQID 1273580656
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3570653
proquest_miscellaneous_1273580656
pubmed_primary_23220917
pascalfrancis_primary_26898096
crossref_primary_10_1164_rccm_201206_1109OC
crossref_citationtrail_10_1164_rccm_201206_1109OC
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-01-15
PublicationDateYYYYMMDD 2013-01-15
PublicationDate_xml – month: 01
  year: 2013
  text: 2013-01-15
  day: 15
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle American journal of respiratory and critical care medicine
PublicationTitleAlternate Am J Respir Crit Care Med
PublicationYear 2013
Publisher American Thoracic Society
Publisher_xml – name: American Thoracic Society
References bib14
bib15
bib12
bib13
bib10
bib32
bib11
bib30
bib31
bib29
bib27
bib28
Gan Y (bib2) 2011; 7
bib25
bib26
bib23
bib24
bib21
bib22
bib20
bib9
bib7
bib8
bib5
bib18
bib6
bib19
bib3
bib16
bib4
bib17
bib1
Wolf AM (bib33) 2003; 9
21339942 - Ther Clin Risk Manag. 2011 Feb 08;7:39-47
21044893 - Int J Biochem Cell Biol. 2011 Jan;43(1):154-62
15289506 - J Exp Med. 2004 Aug 2;200(3):377-89
17377534 - Nature. 2007 Apr 5;446(7136):680-4
11790668 - Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304
21072213 - PLoS One. 2010;5(11):e15404
17585107 - Am J Respir Crit Care Med. 2007 Oct 1;176(7):636-43
20300636 - PLoS One. 2010;5(3):e9683
18342004 - Immunity. 2008 Mar;28(3):302-3
21631273 - Arch Pathol Lab Med. 2011 Jun;135(6):780-8
21484765 - Arthritis Rheum. 2011 Aug;63(8):2484-94
22429962 - Am J Pathol. 2012 May;180(5):1963-78
19543397 - PLoS One. 2009;4(6):e5981
18044734 - Dev Neurobiol. 2008 Feb 15;68(3):317-31
20404807 - Lab Invest. 2010 Jun;90(6):812-23
20815874 - Fibrogenesis Tissue Repair. 2010 Sep 03;3:18
19342412 - Am J Respir Crit Care Med. 2009 Jun 15;179(12):1121-30
21471066 - Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
22896629 - J Immunol. 2012 Sep 15;189(6):3150-8
16713976 - Immunity. 2006 May;24(5):591-600
10088601 - J Leukoc Biol. 1999 Feb;65(2):187-95
18375740 - Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1174-86
18467694 - Am J Pathol. 2008 Jun;172(6):1650-63
12879062 - Nature. 2003 Jul 24;424(6947):398-405
17962367 - J Leukoc Biol. 2008 Feb;83(2):237-44
22198947 - J Immunol. 2012 Feb 1;188(3):1108-16
19770521 - J Clin Invest. 2009 Oct;119(10):2898-913
21868503 - Am J Respir Crit Care Med. 2011 Dec 1;184(11):1270-81
12576425 - Clin Cancer Res. 2003 Feb;9(2):606-12
17641646 - Nat Protoc. 2007;2(7):1789-94
20126467 - PLoS One. 2010;5(1):e8959
21253393 - World J Gastroenterol. 2011 Jan 21;17(3):343-8
20176803 - J Exp Med. 2010 Mar 15;207(3):535-52
References_xml – ident: bib8
  doi: 10.4049/jimmunol.1102084
– ident: bib22
  doi: 10.1152/ajplung.00439.2007
– ident: bib28
  doi: 10.1016/j.immuni.2008.02.012
– volume: 9
  start-page: 606
  year: 2003
  ident: bib33
  publication-title: Clin Cancer Res
– ident: bib13
  doi: 10.1084/jem.20092121
– ident: bib26
  doi: 10.1164/rccm.200703-463PP
– ident: bib31
  doi: 10.1084/jem.20040104
– volume: 7
  start-page: 39
  year: 2011
  ident: bib2
  publication-title: Ther Clin Risk Manag
– ident: bib5
  doi: 10.1038/nature01790
– ident: bib3
  doi: 10.5858/2010-0296-RA.1
– ident: bib16
  doi: 10.1186/1755-1536-3-18
– ident: bib23
  doi: 10.1038/labinvest.2010.73
– ident: bib6
  doi: 10.1038/nature05652
– ident: bib11
  doi: 10.1002/jlb.65.2.187
– ident: bib9
  doi: 10.1002/art.30386
– ident: bib25
  doi: 10.1371/journal.pone.0009683
– ident: bib14
  doi: 10.1016/j.ajpath.2012.01.010
– ident: bib1
  doi: 10.1164/rccm.2009-040GL
– ident: bib15
  doi: 10.1164/rccm.201103-0516OC
– ident: bib7
  doi: 10.1016/j.immuni.2006.03.013
– ident: bib4
  doi: 10.1002/dneu.20592
– ident: bib29
  doi: 10.4049/jimmunol.1201140
– ident: bib12
  doi: 10.2353/ajpath.2008.071049
– ident: bib17
  doi: 10.1371/journal.pone.0015404
– ident: bib18
  doi: 10.1371/journal.pone.0005981
– ident: bib10
  doi: 10.1189/jlb.0707504
– ident: bib21
  doi: 10.1038/nprot.2007.258
– ident: bib24
  doi: 10.1016/j.biocel.2010.10.013
– ident: bib19
  doi: 10.1164/ajrccm.165.2.ats01
– ident: bib27
  doi: 10.1164/rccm.200812-1936OC
– ident: bib30
  doi: 10.1371/journal.pone.0008959
– ident: bib20
  doi: 10.1172/JCI36498
– ident: bib32
  doi: 10.3748/wjg.v17.i3.343
– reference: 18375740 - Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1174-86
– reference: 19342412 - Am J Respir Crit Care Med. 2009 Jun 15;179(12):1121-30
– reference: 21471066 - Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
– reference: 22429962 - Am J Pathol. 2012 May;180(5):1963-78
– reference: 22896629 - J Immunol. 2012 Sep 15;189(6):3150-8
– reference: 21631273 - Arch Pathol Lab Med. 2011 Jun;135(6):780-8
– reference: 10088601 - J Leukoc Biol. 1999 Feb;65(2):187-95
– reference: 18044734 - Dev Neurobiol. 2008 Feb 15;68(3):317-31
– reference: 20404807 - Lab Invest. 2010 Jun;90(6):812-23
– reference: 21253393 - World J Gastroenterol. 2011 Jan 21;17(3):343-8
– reference: 21044893 - Int J Biochem Cell Biol. 2011 Jan;43(1):154-62
– reference: 17641646 - Nat Protoc. 2007;2(7):1789-94
– reference: 21072213 - PLoS One. 2010;5(11):e15404
– reference: 15289506 - J Exp Med. 2004 Aug 2;200(3):377-89
– reference: 19770521 - J Clin Invest. 2009 Oct;119(10):2898-913
– reference: 11790668 - Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304
– reference: 21868503 - Am J Respir Crit Care Med. 2011 Dec 1;184(11):1270-81
– reference: 20176803 - J Exp Med. 2010 Mar 15;207(3):535-52
– reference: 17377534 - Nature. 2007 Apr 5;446(7136):680-4
– reference: 18342004 - Immunity. 2008 Mar;28(3):302-3
– reference: 20126467 - PLoS One. 2010;5(1):e8959
– reference: 19543397 - PLoS One. 2009;4(6):e5981
– reference: 18467694 - Am J Pathol. 2008 Jun;172(6):1650-63
– reference: 17585107 - Am J Respir Crit Care Med. 2007 Oct 1;176(7):636-43
– reference: 21484765 - Arthritis Rheum. 2011 Aug;63(8):2484-94
– reference: 16713976 - Immunity. 2006 May;24(5):591-600
– reference: 12576425 - Clin Cancer Res. 2003 Feb;9(2):606-12
– reference: 20815874 - Fibrogenesis Tissue Repair. 2010 Sep 03;3:18
– reference: 17962367 - J Leukoc Biol. 2008 Feb;83(2):237-44
– reference: 21339942 - Ther Clin Risk Manag. 2011 Feb 08;7:39-47
– reference: 22198947 - J Immunol. 2012 Feb 1;188(3):1108-16
– reference: 12879062 - Nature. 2003 Jul 24;424(6947):398-405
– reference: 20300636 - PLoS One. 2010;5(3):e9683
SSID ssj0012810
Score 2.4176285
Snippet Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation. To define the...
Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte...
Rationale : Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation....
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 180
SubjectTerms Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Antigens, CD - physiology
Biological and medical sciences
CD4-Positive T-Lymphocytes - immunology
CD4-Positive T-Lymphocytes - physiology
Disease Models, Animal
Humans
Idiopathic Pulmonary Fibrosis - etiology
Idiopathic Pulmonary Fibrosis - immunology
Idiopathic Pulmonary Fibrosis - physiopathology
Intensive care medicine
Interleukin-10 - physiology
Medical sciences
Mice
Mice, Inbred C57BL
Mice, Transgenic
Pneumology
Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases
Semaphorins - physiology
T-Lymphocytes, Regulatory - physiology
Transforming Growth Factor beta1 - physiology
Title Semaphorin 7a + Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis
URI https://www.ncbi.nlm.nih.gov/pubmed/23220917
https://www.proquest.com/docview/1273580656
https://pubmed.ncbi.nlm.nih.gov/PMC3570653
Volume 187
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZpCmMwxu7LLkGD9cl4i-SL7MclpITRdiVzIW9GkuU2LEtCEg-6PzXYD9nzfs6OLN_ShNHtxQRbkk2-T9I50qdzEHobUL27xKmtZCpsVwTSBuPIs11PMdmTYCLnWSJOz_zRhftx4k1ard8N1VK2Ee_k973nSv4HVbgHuOpTsv-AbNUo3IDfgC9cAWG43grjz-orX15pCZ3FwAjsWyuTWV7vm0eWXpNfW1rZxQsMSql5LsrS-tdvypom00Wellhay2wGn65ldCk40QsdqiQP5QotTAvhuUpyYWRp7ep1hktw5KFNk7jHPhoMj_qU2ODqZ1pasNtm0xyu9osaASxWjc3__NBdmYwhF6nd1AKM1XT2ZWFCS47zde56dfZcmYFstCimZ0OsFTer9NcwxewWnmTquugxxWKITkxBbHMctBq_PZ00z2z1qD33qkGfNdhNG0M4MZmldqcW3wU-rKTU8QsI1emLSC8sIm9uxfE--xQfX5ycxNFwEh2gQwoODG2jw_7w7Hxc7XDRwETKKD-uPNDlu-9337FlNN1b8jX866lJvLLPM7op8G1YTNEDdL9wdfAHw9uHqKXmj9Cd0wLAx-hHTV_MuIVr8uII5-TFgDiuyYs1eXGDvLgmL66IhkuiYWBP3kJNXgyvapIXG_Ligry_flbE3dPeExQdD6PByC7yh9jScRkMOm4qVUBVyAPuuDBUKZkQn_uMJ0LAVCS9lHIiEuozxsFzSnggpCNCX6Q8DJnzFLXni7l6jrBPiQjTQPDU0fE0He44PeGSJJRKiCBJO4iU-MSyiK2vU7zM4tzH9t1YYxobTGODaQdZVZ2liSzz19LdLdirKtQPwqAX-h30puRBDDOERonP1SJbxwQ8FE_rJ6DMM8OLujbM5-AxsA5iW4ypCujo89tP5tOrPAq942mFhPPiFu99ie7WnfUVam9WmXoNtvxGdNEBmzC4BgPSLbrIHyakBfM
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Semaphorin+7a%2B+regulatory+T+cells+are+associated+with+progressive+idiopathic+pulmonary+fibrosis+and+are+implicated+in+transforming+growth+factor-%CE%B21-induced+pulmonary+fibrosis&rft.jtitle=American+journal+of+respiratory+and+critical+care+medicine&rft.au=Reilkoff%2C+Ronald+A&rft.au=Peng%2C+Hong&rft.au=Murray%2C+Lynne+A&rft.au=Peng%2C+Xueyan&rft.date=2013-01-15&rft.issn=1535-4970&rft.eissn=1535-4970&rft.volume=187&rft.issue=2&rft.spage=180&rft_id=info:doi/10.1164%2Frccm.201206-1109OC&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-449X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-449X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-449X&client=summon